Altimmune Inc [ALT] stock prices are up 1.92% to $7.45 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ALT shares have gain 3.33% over the last week, with a monthly amount drifted -18.22%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Altimmune Inc [NASDAQ: ALT] stock has seen the most recent analyst activity on January 08, 2025, when Stifel initiated its Buy rating and assigned the stock a price target of $18. Previously, UBS started tracking the stock with Buy rating on November 12, 2024, and set its price target to $26. On April 29, 2024, downgrade downgraded it’s rating to Neutral. Goldman started tracking the stock assigning a Neutral rating and suggested a price target of $13 on January 24, 2024. Goldman downgraded its rating to a Neutral and reduced its price target to $6 on March 22, 2023. Goldman started tracking with a Buy rating for this stock on December 01, 2022, and assigned it a price target of $20.
The stock price of Altimmune Inc [ALT] has been fluctuating between $5.28 and $14.84 over the past year. Currently, Wall Street analysts expect the stock to reach $23.6 within the next 12 months. Altimmune Inc [NASDAQ: ALT] shares were valued at $7.45 at the most recent close of the market. An investor can expect a potential return of 216.78% based on the average ALT price forecast.
Analyzing the ALT fundamentals
The Altimmune Inc [NASDAQ:ALT] reported sales of 0.05M for trailing twelve months, representing a drop of -98.62%. Gross Profit Margin for this corporation currently stands at -38.58% with Operating Profit Margin at -1913.65%, Pretax Profit Margin comes in at -1990.77%, and Net Profit Margin reading is -1990.77%. To continue investigating profitability, this company’s Return on Assets is posted at -0.7, Equity is -0.63 and Total Capital is -0.71.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 7.22 points at the first support level, and at 7.00 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.75, and for the 2nd resistance point, it is at 8.06.
Ratios To Look Out For
It’s worth pointing out that Altimmune Inc [NASDAQ:ALT]’s Current Ratio is 16.87. Further, the Quick Ratio stands at 16.87, while the Cash Ratio is 3.64. Considering the valuation of this stock, the price to sales ratio is 10597.55, the price to book ratio is 3.97.
Transactions by insiders
Recent insider trading involved Drutz David, Director, that happened on Aug 19 ’24 when 16011.0 shares were sold.
